<DOC>
	<DOCNO>NCT01005823</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability pharmacokinetics 7 day treatment LEO 29102 adult patient atopic dermatitis .</brief_summary>
	<brief_title>A Safety , Tolerability Pharmacokinetic Study LEO 29102 Subjects With Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Age 1855 year Atopic dermatitis 8501700cm2 In good health Criteria exclusion : Comorbid condition Hepatic dysfunction Clinical infection Immunocompromised status Clinically significant illness Use immunomodulating treatment Medications relate respiratory system heart rhythm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2010</verification_date>
</DOC>